KARNF yields 33.33% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, KARNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KARNF + PFE for your $10,000?
Kernel Holding S.A., together with its subsidiaries, engages in the diversified agricultural business in Ukraine, Singapore, India, China, Switzerland, the Netherlands, and internationally. It operates through three segments: Oilseed Processing, Infrastructure and Trading, and Farming. The Oilseed Processing segment is involved in the origination, production, and sale of bottled and bulk sunflower oil, and meal products; and production of renewable energy from biomass. The Infrastructure and Trading segment provides grain handling, and logistics and transshipment services; grain and oilseed cleaning, drying, and storage services; and proprietary trading and silo services, as well as sourcing and merchandising services of wholesale edible oils and grains. The Farming segment engages in agricultural farming; and the production of corn, wheat, soybean, sunflower seed, and rapeseed. Kernel Holding S.A. was founded in 1995 and is headquartered in Kyiv, Ukraine.
Full KARNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.